| Matthew Zore, | |
|
1160 W Michigan St, Indianapolis, IN 46202-5209 | |
| (317) 274-2020 | |
| Not Available |
| Full Name | Matthew Zore |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 12 Years |
| Location | 1160 W Michigan St, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609142785 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | A141500 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peninsula Medical Center | Burlingame, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peninsula Ophthalmology Group Inc | 0042281164 | 9 |
News Archive
By 2050, a 60% increase in wheat production will be needed to meet the demand of a growing population. The Wheat Initiative, an international consortium gathering public institutions and private companies, was created as part of the 2011 action plan of the G20 Agricultural Ministries to coordinate global wheat research and participate to global food security.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
A recent analysis of a US commercial insurance database found that adults with rheumatoid arthritis had a lower risk of developing type 2 diabetes than other individuals, including those with other types of arthritis.
The new prices will kick in July 1 and are expected to save on average 45 percent for products such as walkers, wheelchairs, oxygen equipment and other medical products.
Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately.
› Verified 1 days ago
| Entity Name | Peninsula Ophthalmology Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447303995 PECOS PAC ID: 0042281164 Enrollment ID: O20040803000863 |
News Archive
By 2050, a 60% increase in wheat production will be needed to meet the demand of a growing population. The Wheat Initiative, an international consortium gathering public institutions and private companies, was created as part of the 2011 action plan of the G20 Agricultural Ministries to coordinate global wheat research and participate to global food security.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
A recent analysis of a US commercial insurance database found that adults with rheumatoid arthritis had a lower risk of developing type 2 diabetes than other individuals, including those with other types of arthritis.
The new prices will kick in July 1 and are expected to save on average 45 percent for products such as walkers, wheelchairs, oxygen equipment and other medical products.
Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately.
› Verified 1 days ago
| Entity Name | William D Mosier Md Inc A Professional Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003476508 PECOS PAC ID: 2365877958 Enrollment ID: O20200108000962 |
News Archive
By 2050, a 60% increase in wheat production will be needed to meet the demand of a growing population. The Wheat Initiative, an international consortium gathering public institutions and private companies, was created as part of the 2011 action plan of the G20 Agricultural Ministries to coordinate global wheat research and participate to global food security.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
A recent analysis of a US commercial insurance database found that adults with rheumatoid arthritis had a lower risk of developing type 2 diabetes than other individuals, including those with other types of arthritis.
The new prices will kick in July 1 and are expected to save on average 45 percent for products such as walkers, wheelchairs, oxygen equipment and other medical products.
Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Zore, 1720 El Camino Real, Ste 225, Burlingame, CA 94010-3230 Ph: (650) 483-5749 | Matthew Zore, 1160 W Michigan St, Indianapolis, IN 46202-5209 Ph: (317) 274-2020 |
News Archive
By 2050, a 60% increase in wheat production will be needed to meet the demand of a growing population. The Wheat Initiative, an international consortium gathering public institutions and private companies, was created as part of the 2011 action plan of the G20 Agricultural Ministries to coordinate global wheat research and participate to global food security.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
A recent analysis of a US commercial insurance database found that adults with rheumatoid arthritis had a lower risk of developing type 2 diabetes than other individuals, including those with other types of arthritis.
The new prices will kick in July 1 and are expected to save on average 45 percent for products such as walkers, wheelchairs, oxygen equipment and other medical products.
Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately.
› Verified 1 days ago
Dr. Frank N. Hrisomalos, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St Ste 1070, Indianapolis, IN 46290 Phone: 317-817-1500 Fax: 317-817-1511 | |
Dr. Sang Hoon Kim, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9002 N Meridian St, Suite 102, Indianapolis, IN 46260 Phone: 317-573-4410 Fax: 317-573-4412 | |
Dr. David V Poer, M.D., F.A.C.S. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8902 N Meridian St, Ste 120, Indianapolis, IN 46260 Phone: 317-582-1118 Fax: 317-582-1116 | |
Scott Hobson, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 10300 N Illinois St, Suite 2020, Indianapolis, IN 46290 Phone: 317-817-1976 Fax: 317-817-1737 | |
John Thomas Minturn, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St, Suite #1030, Indianapolis, IN 46290 Phone: 317-817-1586 Fax: 317-817-1399 | |
Amir Reza Hajrasouliha, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1160 W Michigan St, Indianapolis, IN 46202 Phone: 317-944-2020 | |
Keith R Knuth, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 901 E 86th St, Indianapolis, IN 46240 Phone: 317-844-5500 Fax: 317-573-4230 |